Analytical Data
-
基因名
MUC-17
- Application
-
别名
(MUC-17)(Small intestinal mucin-3)(MUC-3)
-
种属
Human
-
表达系统
HEK293
-
标签
C- His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
Q685J3
-
表达区间
4131-4390aa
-
分子量
32.0kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MUC-17, a member of the mucin family of glycoproteins, is primarily expressed in epithelial tissues and plays a crucial role in maintaining mucosal barrier integrity and facilitating cell signaling processes. Research has increasingly focused on MUC-17 due to its potential implications in various diseases, including cancer, where it may influence tumor progression and metastasis. Studies have shown that alterations in MUC-17 expression can correlate with disease states, making it a promising biomarker for diagnosis and prognosis. Additionally, the investigation of MUC-17's structure and function can provide insights into its role in pathogen interactions and immune responses. The development of recombinant MUC-17 protein has enabled researchers to explore its biochemical properties and functional mechanisms in vitro and in vivo. This lines of research not only contribute to our understanding of mucosal biology but also pave the way for novel therapeutic approaches targeting MUC-17 in disease management. Overall, MUC-17 continues to be a focal point for translational research, with ongoing studies aimed at elucidating its multifaceted roles in health and disease.
